Timely Curative Treatment and Overall Mortality Among Veterans With Stage I NSCLC

Timely Curative Treatment and Overall Mortality Among Veterans With Stage I NSCLC

Introduction: Early stage lung cancer (LC) outcomes depend on the receipt of timely therapy. We aimed to determine the proportions of Veterans with stage I NSCLC in the age group eligible for LC screening (LCS) receiving timely curative treatment (≤12 wk after diagnosis), the factors associated with...

Full description

Bibliographic Details
Main Authors:	Rolando Sanchez, MD, MS, Mary S. Vaughan Sarrazin, PhD, Richard M. Hoffman, MD, MPH
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	JTO Clinical and Research Reports
Subjects:	Veterans Early-stage lung cancer Non–small cell lung cancer Lung cancer screening
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364322001795

Similar Items

Lung Cancer Screening Among U.S. Military Veterans by Health Status and Race and Ethnicity, 2017–2020: A Cross-Sectional Population-Based Study
by: Alison S. Rustagi, MD, PhD, et al.
Published: (2023-06-01)

Lung Segmentectomy in NSCLC Surgery
by: Alberto Salvicchi, et al.
Published: (2023-05-01)

Epidemiological and therapeutic profiles of lung cancer patients in the Hokushin Region Japan: a retrospective hospital administrative database study
by: Takashi Kobayashi, et al.
Published: (2023-09-01)

Effective Communication About Lung Cancer Screening Without Iatrogenic Stigma: A Brief Report Case Study Using the Lung Cancer Stigma Communications Assessment Tool of LungTalk
by: Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, et al.
Published: (2023-11-01)

Racial and Ethnic Trends and Disparities in NSCLC
by: Kristin M. Primm, MPH, PhD, et al.
Published: (2022-08-01)

Results of Treatment with Stereotactic Radiotherapy in Patients with Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
by: Cengiz Gemici
Published: (2017-06-01)

The majority of patients with resectable incidental lung cancers are ineligible for lung cancer screeningCentral MessagePerspective
by: Nanruoyi Zhou, MD, et al.
Published: (2023-03-01)

Incidental pulmonary nodules may lead to a high proportion of early-stage lung cancer: but it requires more than a high CT volume to achieve this
by: M. Borg, et al.
Published: (2024-12-01)

Standardization of Minimum Requirements for the Formation of an Early Detection Center for Lung Cancer in Latin America
by: Sebastian Blas Lamot, et al.
Published: (2024-03-01)

Understanding the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos: A qualitative study
by: Edgar I. Alaniz-Cantú, et al.
Published: (2024-03-01)

Future Perspectives on the TNM Staging for Lung Cancer
by: Ramón Rami-Porta
Published: (2021-04-01)

VATS versus Open Lobectomy following Induction Therapy for Stage III NSCLC: A Propensity Score-Matched Analysis
by: Kheira Hireche, et al.
Published: (2023-01-01)

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
by: Chiara Lazzari, et al.
Published: (2023-03-01)

Results of a pilot risk-based lung cancer screening study: outcomes and comparisons to a Medicare eligible cohort
by: Erin A. Hirsch, et al.
Published: (2023-08-01)

Surgical intervention may be a therapeutic option for NSCLC patients with AJCC stage IV: a large population-based study
by: Wang H, et al.
Published: (2018-09-01)

Spatial and spatio-temporal clusters of lung cancer incidence by stage of disease in Michigan, United States 1985-2018
by: Qiong Zhang, et al.
Published: (2024-02-01)

The Negative Consequences of False Negative Lung Cancer Screenings
by: Hoda Shabpiray, et al.
Published: (2023-12-01)

A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
by: Irene Terrenato, et al.
Published: (2022-06-01)

Artificial Intelligence Tools for Refining Lung Cancer Screening
by: J. Luis Espinoza, et al.
Published: (2020-11-01)

Optimizing the implementation of lung cancer screening in Scotland: Focus group participant perspectives in the LUNGSCOT study
by: Debbie Cavers, et al.
Published: (2022-12-01)

Impact of examined lymph node count on long-term survival of T1-2N0M0 double primary NSCLC patients after surgery: a SEER study
by: Kan Jiang, et al.
Published: (2020-02-01)

Lung cancer risk score for ever and never smokers in China
by: Zhimin Ma, et al.
Published: (2023-08-01)

Perspectives on early‐stage lung cancer identification and challenges to thoracic surgery
by: Xiao Li, et al.
Published: (2022-06-01)

The Impact of Immunotherapy Use in Stage IIIA (T1-2N2) NSCLC: A Nationwide Analysis
by: Lye-Yeng Wong, MD, et al.
Published: (2024-03-01)

Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer
by: Kamya Sankar, et al.
Published: (2022-01-01)

Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
by: Zi-Qing Shen, et al.
Published: (2024-01-01)

Lung cancer screening: the hidden public health emergency
by: Emily Stone, et al.
Published: (2023-03-01)

Treatment of Stage I Lung Cancer Detected by Computed Tomography Screening
by: David S. Gierada, MD, et al.
Published: (2022-10-01)

Local control and survival after stereotactic body radiation therapy of early-stage lung cancer patients in Slovenia
by: Stanic Karmen, et al.
Published: (2023-07-01)

Lung Cancer Screening in Greece: A Modelling Study to Estimate the Impact on Lung Cancer Life Years
by: Kyriakos Souliotis, et al.
Published: (2022-11-01)

Updates and Controversies in the Rapidly Evolving Field of Lung Cancer Screening, Early Detection, and Chemoprevention
by: Hasmeena Kathuria, et al.
Published: (2014-05-01)

Brief report: risk stratification following curative therapy for stage I NSCLC
by: Emily Butts, et al.
Published: (2023-08-01)

The characteristics and prognosis of different disease patterns of multiple primary lung cancers categorized according to the 8th edition lung cancer staging system
by: Yalong Wang, et al.
Published: (2024-04-01)

A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection
by: Lun Zhang, et al.
Published: (2020-03-01)

Public Attitudes Towards Lung Cancer Screening in Saudi Arabia: A Cross-Sectional Study
by: Dairi MS, et al.
Published: (2023-08-01)

Lung cancer screening in Appalachian Kentucky: The impact of Lung-RADS on subsequent testing and cancer identification
by: Roberto Cardarelli, et al.
Published: (2020-10-01)

The role of lung cancer risk and comorbidity in lung cancer screening use
by: Ilana B. Richman, et al.
Published: (2022-12-01)

Brief Report: Increasing Prevalence of Ground-Glass Nodules and Semisolid Lung Lesions on Outpatient Chest Computed Tomography Scans
by: Gavitt A. Woodard, MD, et al.
Published: (2023-12-01)

Lung cancer screening has the potential to save lives, but shall we do it?
by: EW Russi
Published: (2011-04-01)

Prognostic Significance of the Extranodal Extension of Regional Lymph Nodes in Stage III-N2 Non-Small-Cell Lung Cancer after Curative Resection
by: Beatrice Chia-Hui Shih, et al.
Published: (2021-07-01)